Konu "Sacubitril/Valsartan" için Tıp Fakültesi listeleme
Toplam kayıt 2, listelenen: 1-2
-
Angiotensin receptor neprilysin inhibitor for patients with heart failure and reduced ejection fraction: Real-world experience from Turkey (ARNi-TR)
(Turkish Society of Cardiology, 2021)Objective: Heart failure (HF) is a growing public health problem with high morbidity and mortality. Recently, angiotensin receptor neprilysin inhibitor (ARNi) has emerged as a promising treatment for HF with reduced ejection ... -
The impact of the use of sacubitril/valsartan on clinical and echocardiographic parameters in heart failure patients
(Wiley, 2019)Background: Sacubitril/valsartan is a guideline-recommended alternative drug to Angiotensin-Converting enzyme inhibitors (ACEIs) or Angiotensin II Receptor Blockers (ARBs) to reduce morbidity and mortality in patients with ...